Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)

Germany flag Germany · Delayed Price · Currency is EUR
0.9650
+0.0700 (7.82%)
At close: Jan 9, 2026
-4.46%
Market Cap650.65M
Revenue (ttm)89.95M
Net Income (ttm)3.81M
Shares Outn/a
EPS (ttm)0.01
PE Ratio170.90
Forward PE37.87
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume37
Open0.9650
Previous Close0.8950
Day's Range0.9650 - 0.9650
52-Week Range0.8350 - 2.1200
Betan/a
RSI51.00
Earnings DateMar 25, 2026

About FRA:UJ9

Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of post... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 760
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol UJ9
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.